ALK-Abelló A/S (ALK-B) - Total Liabilities
Based on the latest financial reports, ALK-Abelló A/S (ALK-B) has total liabilities worth Dkr2.73 Billion DKK (≈ $426.66 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does ALK-Abelló A/S generate cash to assess how effectively this company generates cash.
ALK-Abelló A/S - Total Liabilities Trend (2005–2025)
This chart illustrates how ALK-Abelló A/S's total liabilities have evolved over time, based on quarterly financial data. Check ALK-B asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
ALK-Abelló A/S Competitors by Total Liabilities
The table below lists competitors of ALK-Abelló A/S ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BYD Electronic (International) Company Limited
F:4BY
|
Germany | €49.75 Billion |
|
Planet Labs PBC
NYSE:PL
|
USA | $756.50 Million |
|
The Federal Bank Limited
NSE:FEDERALBNK
|
India | Rs3.31 Trillion |
|
Inpost SA
AS:INPST
|
Netherlands | €13.48 Billion |
|
Commercial Metals Company
NYSE:CMC
|
USA | $4.93 Billion |
|
Thai Beverage Public Company Limited
F:T6W
|
Germany | €304.21 Billion |
|
Shenzhen Capchem Tech
SHE:300037
|
China | CN¥7.74 Billion |
|
UGI Corporation
NYSE:UGI
|
USA | $10.80 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down ALK-Abelló A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of ALK-Abelló A/S.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ALK-Abelló A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ALK-Abelló A/S (2005–2025)
The table below shows the annual total liabilities of ALK-Abelló A/S from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Dkr2.73 Billion ≈ $426.66 Million |
-5.08% |
| 2024-12-31 | Dkr2.87 Billion ≈ $449.50 Million |
+26.06% |
| 2023-12-31 | Dkr2.28 Billion ≈ $356.57 Million |
-1.77% |
| 2022-12-31 | Dkr2.32 Billion ≈ $362.98 Million |
-1.28% |
| 2021-12-31 | Dkr2.35 Billion ≈ $367.67 Million |
-2.49% |
| 2020-12-31 | Dkr2.41 Billion ≈ $377.06 Million |
+3.92% |
| 2019-12-31 | Dkr2.32 Billion ≈ $362.82 Million |
+37.54% |
| 2018-12-31 | Dkr1.69 Billion ≈ $263.79 Million |
+1.08% |
| 2017-12-31 | Dkr1.67 Billion ≈ $260.97 Million |
-13.31% |
| 2016-12-31 | Dkr1.92 Billion ≈ $301.02 Million |
+23.73% |
| 2015-12-31 | Dkr1.55 Billion ≈ $243.29 Million |
+46.01% |
| 2014-12-31 | Dkr1.06 Billion ≈ $166.63 Million |
+4.51% |
| 2013-12-31 | Dkr1.02 Billion ≈ $159.43 Million |
+2.10% |
| 2012-12-31 | Dkr998.00 Million ≈ $156.14 Million |
-15.92% |
| 2011-12-31 | Dkr1.19 Billion ≈ $185.71 Million |
+46.18% |
| 2010-12-31 | Dkr812.00 Million ≈ $127.04 Million |
+12.00% |
| 2009-12-31 | Dkr725.00 Million ≈ $113.43 Million |
+7.25% |
| 2008-12-31 | Dkr676.00 Million ≈ $105.77 Million |
-4.65% |
| 2007-12-31 | Dkr709.00 Million ≈ $110.93 Million |
+2.01% |
| 2006-12-31 | Dkr695.00 Million ≈ $108.74 Million |
-1.70% |
| 2005-12-31 | Dkr707.00 Million ≈ $110.62 Million |
-- |
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for th… Read more